Navigation Links
MabPlex International Ltd. Secures $59.1 Million Series A Financing Round
Date:1/30/2019

MabPlex International Ltd, a leading and fully integrated Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China and the United States, has closed its series A funding of $59.1 million backed by multiple global investors lead by China's State Development & Investment Corporation (SDIC) and Shenzhen Venture capital. 

This financing round will support upgrades to MabPlex’s technology platform, Phase III and commercial production expansion, as well as the company’s international strategy.

"With our professional services and international standards, R&D companies can not only shorten product development time, but more importantly, they can use limited funds for new drug projects themselves, reduce R&D risks and increase corporate value," said Jianmin Fang, Ph.D, Chairman and Chief Executive Officer of MabPlex International, Ltd.

"This financing will greatly enhance our service capabilities, we will continue to provide high quality services to our customers," Fang added.

About MabPlex
MabPlex International Ltd, a leading and fully integrated Contract Development and Manufacturing Organization (CDMO), offers an advanced biologics platform and comprehensive and integrated solutions to global biopharmaceutical developers. Founded in 2013, MabPlex currently has two sites in China (Yantai and Shanghai) and one site in the United States (San Diego, CA) offering high quality services from biologics drug development to commercial manufacturing. With our state-of-the-art facilities and exemplary biologics development and manufacturing experience, MabPlex commits to being a valuable partner for our clients around the globe.

Read the full story at https://www.prweb.com/releases/mabplex_international_ltd_secures_59_1_million_series_a_financing_round/prweb16064155.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. MabPlex International, Ltd. Opens New Phase III and Commercial Manufacturing Facility
2. Heart failure caregivers face critical gaps in resources and support, new international study shows
3. New Ag International will host the 3rd Biostimulants World Congress in Miami, 27-30 November 2017
4. CNA Finance Initiates Research Coverage On Youngevity International
5. Distinguished Cardiologists and Scientists Honored with 2017 International Academy of Cardiology Awards at the 22nd World Congress on Heart Disease, Vancouver, BC, Canada
6. National Aeromodeling Championships Underway at International Aeromodeling Center
7. GigaGen Announces Launch of New Antibody Discovery Service at 2017 BIO International Conference
8. MimiVax Appoints Jerry Jacobs Jr. to Board of Directors; SurVaxM Immunotherapy Partnership Opportunities at BIO International June 19-22, 2017.
9. MMJ International Holdings Enters Cannabis Study Agreement with BioInformatics and Genomics Center (BIG) at the University of Buffalo, New York
10. SPIE Supports International Day of Light to Promote Awareness of Life-saving, Live-enhancing light
11. Delpor Selected by the NIH to Exhibit its Technology at the 2017 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2019)... POWAY, Calif. (PRWEB) , ... June 18, 2019 , ... ... submitted an Investigational New Drug (IND) application to the FDA for use of a ... stem cells as a treatment of osteoarthritis in the knee. This IND is ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s ... of more than 20 million articles, sourced from more than 15,000 journals. , ...
(Date:6/6/2019)... ... , ... WCCT Global, Inc ., a full-service early phase contract research ... be receiving 3 awards at the 2019 CRO Leadership Awards, to be held on ... of overall Quality and Compatibility (Access to desired markets, cultural fit, timely project communications ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally ... acquisition provides Object exclusive ownership and commercialization rights to a full spectrum of ...
Breaking Biology Technology:
(Date:6/16/2019)... (PRWEB) , ... June 14, 2019 , ... ... multi-pillar Oracle Cloud customer, will deliver a joint presentation with Versiti’s CIO at ... June 16-19 at the Rosen Shingle Creek Resort. , Versiti Vice President and ...
(Date:6/11/2019)... ... June 10, 2019 , ... Improved Pharma LLC announces the ... issue of AAPS PharmSciTech. The article was published online on April 29th, 2019. The ... along with Xiaoming Sean Chen of Purdue University. , The article is the most ...
(Date:6/4/2019)... , ... June 04, 2019 , ... ... announced the appointment of Susan Murphy as the new President of Molecular Devices, ... by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in ...
Breaking Biology News(10 mins):